Drug Safety in Developing Countries Achievements and Challenges

Langue : Anglais

Coordonnateur : Al-Worafi Yaser Mohammed

Couverture de l’ouvrage Drug Safety in Developing Countries

Résumé
Sommaire
Lectorat
Biographie
Commentaire

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries.

Section 1 Drug safety-related issues 1. Introduction: Why do we need a book on drug safety in developing countries? 2. Medications safety-related terminology 3. Medications registration and marketing: safety-related issues 4. Pharmacovigilance 5. Adverse drug reactions 6. Medication errors 7. Self-medication 8. Antibiotics safety issue 9. Drug-related problems 10. Counterfeit and substandard medications 11. Medication abuse and misuse 12. Storage and disposal of medications 13. Safety of medications in special population 14. Herbal medicines safety issues 15. Medications safety resources and tools 16. Medications safety pharmacoeconomics-related issues 17. Evidence-based medications safety practice 18. Technology in medications safety 19. Medications safety research issues 20. Quality indicators for medications safety

Section 2: Drug Safety in Asia 21. Drug safety in Malaysia 22. Drug safety in Thailand 23. Drug safety in Indonesia 24. Drug safety in Pakistan 25. Drug safety in India 26. Drug safety in Nepal 27. Drug safety in Sri Lanka 28. Drug Safety in China

Section 3: Drug Safety in Middle East 29. Drug safety in Yemen 30. Drug safety in Saudi Arabia 31. Drug safety in UAE 32. Drug safety in Jordan 33. Drug safety in Lebanon 34. Drug safety in Palestine 35. Drug safety in Qatar

Section 4: Drug Safety in Africa 36. Drug safety in Sudan 37. Drug safety in Egypt 38. Drug safety in Nigeria 39. Drug safety in Mali 40. Drug safety in Burkina Faso

Section 5: Drug Safety in Latin America 41. Drug safety in Chile

Section 6: Comparisons and conclusions 42. Compare between the developing countries 43. Drug Safety in Developing Versus Developed countries

Primary: Researchers and advanced students in biomedical sciences, cell biology, physiology, pathology and pharmacology.

Secondary: Clinicians and pathologists interested in tissue barrier diseases.

Prof. Yaser Mohammed Al-Worafi is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, UAE (Previously known as Ajman University). He graduated with a bachelor's degree in Pharmacy (BPharm) from Sana’a University, Yemen and obtained a Master and PhD degree in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. He has more than 20 years experience in education, practice and research in Yemen, Saudi Arabia, United Arab Emirates and Malaysia. He has held various academic and professional positions including Deputy Dean for Medical Sciences College; PharmD program director, Head of Clinical Pharmacy/Pharmacy Practice department; Head of Teaching & learning committee, Head of Training Committee, head of the curriculum committee and other committees. He has authored over 100 peer-reviewed papers in international journals, and book chapters and edited more than 10 books by Elsevier, Springer, Taylors & Francis, USA. Prof.Yaser has supervised/co-supervised many PhD, Master, PharmD and B-Pharm students. He is a reviewer for eight recognized international peer-reviewed journals. Prof. Yaser prepared, designed, and wrote many pharmacy programs for many universities including Master of Clinical Pharmacy/Pharmacy Practice program; PharmD program and BPharm program; internship/clerkships for Master, PharmD and BPharm programs; more than 30 courses related to Clinical Pharmacy, Pharmacy Practice, Social Pharmacy and Patients care.

Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues
Describes current achievements of drug safety practice in developing countries
Addresses the challenges of drug safety in developing countries
Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety